Biomarker Discovery, Validation and Applications

Organizer(s): Mark S. Boguski and Jean-Jacques Garaud

Supported by the Director's Fund

For important information on the coronavirus, please click here

Summary of Meeting:

Conceptually, biomarkers are emerging as a new organizing principle for translational research involving multidisciplinary and parallel activities in basic research, technology development and clinical application. The primary reason for this is that the concept encompasses a broad swath of potential roles in human disease including prevention, diagnosis, prognosis, patient stratification and the pharmacodynamic and pharmacokinetic properties of drugs as well as their efficacies and toxicities. This meeting attempts to bring together scientists, technologists and research physicians to focus attention on key challenges and highlight synergies among groups working in different but overlapping areas. The meeting will address major trends in the field from macromolecular analytics to clinical imaging and overall strategies for biomarker development and applications.

Scholarship Deadline: October 3 2007

Discounted Abstract Deadline: October 3 2007

Abstract Deadline: November 1 2007

Discounted Registration Deadline: December 3 2007

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Applied Biosystems

Merck & Co., Inc.

We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13CA132374-01

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations